UMB Financial Corporation
UMB Financial Corporation (UMBF) Financial Performance & Income Statement Overview
Analyze UMB Financial Corporation (UMBF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
UMB Financial Corporation (UMBF) Income Statement & Financial Overview
View the income breakdown for UMB Financial Corporation UMBF across both annual and quarterly reports.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $850.52M | $680.22M | $674.26M | $641.68M |
Cost of Revenue | $426.33M | $304.99M | $328.32M | $307.22M |
Gross Profit | $424.19M | $375.22M | $345.94M | $334.46M |
Gross Profit Ratio | $0.50 | $0.55 | $0.51 | $0.52 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $229.40M | $170.06M | $153.80M | $149.46M |
Operating Expenses | $331.14M | $230.40M | $210.28M | $207.55M |
Total Costs & Expenses | $757.47M | $535.39M | $538.59M | $514.77M |
Interest Income | $737.97M | $554.97M | $557.69M | $538.28M |
Interest Expense | $340.33M | $285.99M | $310.32M | $293.17M |
Depreciation & Amortization | $29.37M | $12.71M | $12.95M | $13.29M |
EBITDA | $122.42M | $157.54M | $148.61M | $140.20M |
EBITDA Ratio | $0.14 | $0.23 | $0.22 | $0.22 |
Operating Income | $93.05M | $144.82M | $135.66M | $126.91M |
Operating Income Ratio | $0.11 | $0.21 | $0.20 | $0.20 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax | $93.05M | $144.82M | $135.66M | $126.91M |
Income Before Tax Ratio | $0.11 | $0.21 | $0.20 | $0.20 |
Income Tax Expense | $11.72M | $24.83M | $26.02M | $25.57M |
Net Income | $81.33M | $120.00M | $109.64M | $101.34M |
Net Income Ratio | $0.10 | $0.18 | $0.16 | $0.16 |
EPS | $1.22 | $2.46 | $2.25 | $2.08 |
Diluted EPS | $1.21 | $2.44 | $2.23 | $2.07 |
Weighted Avg Shares Outstanding | $48.81M | $48.81M | $48.77M | $48.74M |
Weighted Avg Shares Outstanding (Diluted) | $49.18M | $49.18M | $49.08M | $48.97M |
Over the past four quarters, UMB Financial Corporation demonstrated steady revenue growth, increasing from $641.68M in Q2 2024 to $850.52M in Q1 2025. Operating income reached $93.05M in Q1 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $122.42M, reflecting operational efficiency. Net income dropped to $81.33M, with EPS at $1.22. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan